Simultaneous profiling of solubility and crystallization tendency on ORYL F1
Apparent solubility and precipitate character, for early formulation-pathway decisions, using combined Second Harmonic Scattering (SHS) and Linear Light Scattering (LLS)
Louis Dumas¹, Jitka Kalasová², Martin Kuentz², Orly Tarun¹; based on the peer-reviewed study by Jitka Kalasová et al. (2026)
¹ORYL Photonics SA, Route de la Corniche 5B, 1066 Epalinges, Switzerland
²FHNW School of Life Sciences, Institute for Pharma Technology and Biotechnology, Muttenz, Switzerland
Summary
Solubility screens report the concentration at which a compound precipitates, but not what form the precipitate takes. That form matters for formulation. A compound that crystallizes quickly cannot hold a supersaturated concentration for long. A compound that first separates as an amorphous or liquid-like drug-rich phase may suit supersaturating formulations such as amorphous solid dispersions. This application note shows how a single ORYL F1 experiment answers both questions from the same wells, using Ultrafast Light Scattering (ULS).
Linear Light Scattering (LLS) shows when a compound precipitates and gives its apparent solubility. Second Harmonic Scattering (SHS), recorded in the same 15-minute plate scan, shows whether the precipitate has crystal-like order. The data come from a peer-reviewed study of twelve poorly water-soluble drugs read at 1 h and 24 h (Kalasová, Tarun and Kuentz, Eur. J. Pharm. Sci. 2026). LLS onsets at 24 h matched a solvent-shift HPLC-UV reference (r = 0.91 on log values) and resolved onsets down to 0.1 µM, using 15 to 500 µg of compound per dilution series. At 1 h, SHS rose together with LLS for most compounds. For lopinavir, loratadine and ritonavir, three good glass formers whose precipitates looked spherical under electron microscopy, SHS rose only 4 to 20 times higher in concentration than LLS. The result is an early read on crystallization tendency, taken on the screening plate before compounds are ranked on solubility.